Cemsidomide in Combination With Elranatamab
A Phase 1B, Open-label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Near Add Your Location
Sorting 16 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Not yet accepting
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
- Not yet accepting
- Not yet accepting
- Not yet accepting
- Not yet accepting
Perlmutter Cancer Center at NYU Langone Arena Oncology
North New Hyde Park, NY
- Not yet accepting
- Not yet accepting
- Not yet accepting
- Not yet accepting
- Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.